ITOS: Iteos Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Iteos Therapeutics Inc (ITOS).
$280.58M Market Cap.
ITOS Market Cap. (MRY)
ITOS Shares Outstanding (MRY)
ITOS Assets (MRY)
Total Assets
$686.98M
Total Liabilities
$96.68M
Total Investments
$512.87M
ITOS Income (MRY)
Revenue
$35.00M
Net Income
-$134.41M
Operating Expense
$194.53M
ITOS Cash Flow (MRY)
CF Operations
-$98.18M
CF Investing
-$131.15M
CF Financing
$122.24M
ITOS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $686,976,000 (2.90%) | $667,588,000 (-11.58%) | $754,991,000 (-14.66%) | $884,712,000 (156.77%) |
Assets Current | $509,539,000 (-7.47%) | $550,652,000 (-12.36%) | $628,298,000 (-28.17%) | $874,713,000 (157.61%) |
Assets Non-Current | $177,437,000 (51.74%) | $116,936,000 (-7.70%) | $126,693,000 (1167.06%) | $9,999,000 (99.42%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $590,294,000 (2.62%) | $575,228,000 (-13.28%) | $663,332,000 (19.99%) | $552,820,000 (71.05%) |
Property Plant & Equipment Net | $9,984,000 (-6.97%) | $10,732,000 (58.45%) | $6,773,000 (-8.49%) | $7,401,000 (447.41%) |
Cash & Equivalents | $142,430,000 (-43.36%) | $251,451,000 (-11.78%) | $285,038,000 (-66.42%) | $848,835,000 (152.29%) |
Accumulated Other Comprehensive Income | -$15,999,000 (-20.84%) | -$13,240,000 (-37.29%) | -$9,644,000 (-847.35%) | -$1,018,000 (-264.99%) |
Deferred Revenue | $1,397,000 (-32.28%) | $2,063,000 (-85.02%) | $13,775,000 (-95.10%) | $281,052,000 (6165.09%) |
Total Investments | $512,871,000 (34.51%) | $381,278,000 (-14.62%) | $446,584,000 (0%) | $0 (0%) |
Investments Current | $352,517,000 (25.57%) | $280,739,000 (-14.50%) | $328,359,000 (0%) | $0 (0%) |
Investments Non-Current | $160,354,000 (59.49%) | $100,539,000 (-14.96%) | $118,225,000 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $805,000 (0%) | $0 (0%) | $1,001,000 (-75.11%) | $4,022,000 (2924.06%) |
Trade & Non-Trade Payables | $8,503,000 (-59.66%) | $21,080,000 (175.12%) | $7,662,000 (48.92%) | $5,145,000 (70.03%) |
Accumulated Retained Earnings (Deficit) | -$9,781,000 (-107.85%) | $124,633,000 (-47.47%) | $237,275,000 (68.73%) | $140,623,000 (290.29%) |
Tax Assets | $8,792,000 (-20.13%) | $11,008,000 (329.66%) | $2,562,000 (-74.56%) | $10,072,000 (189.59%) |
Tax Liabilities | $46,720,000 (14.15%) | $40,930,000 (4.41%) | $39,200,000 (130.59%) | $17,000,000 (0%) |
Total Debt | $5,096,000 (-15.88%) | $6,058,000 (29.64%) | $4,673,000 (-12.51%) | $5,341,000 (0%) |
Debt Current | $1,336,000 (6.79%) | $1,251,000 (49.64%) | $836,000 (8.57%) | $770,000 (0%) |
Debt Non-Current | $3,760,000 (-21.78%) | $4,807,000 (25.28%) | $3,837,000 (-16.06%) | $4,571,000 (0%) |
Total Liabilities | $96,682,000 (4.68%) | $92,360,000 (0.76%) | $91,659,000 (-72.38%) | $331,892,000 (1453.73%) |
Liabilities Current | $40,360,000 (0.86%) | $40,014,000 (-4.73%) | $42,000,000 (-86.19%) | $304,124,000 (1927.76%) |
Liabilities Non-Current | $56,322,000 (7.60%) | $52,346,000 (5.41%) | $49,659,000 (78.84%) | $27,768,000 (336.40%) |
ITOS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $35,000,000 (177.89%) | $12,595,000 (-95.29%) | $267,630,000 (-22.38%) | $344,775,000 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $49,081,000 (-2.61%) | $50,396,000 (14.67%) | $43,947,000 (8.50%) | $40,505,000 (164.05%) |
Research & Development Expense | $145,447,000 (28.37%) | $113,300,000 (16.37%) | $97,359,000 (63.99%) | $59,369,000 (98.56%) |
Operating Expenses | $194,528,000 (18.83%) | $163,696,000 (15.85%) | $141,306,000 (41.48%) | $99,874,000 (120.76%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $14,072,000 (289.59%) | $3,612,000 (-93.07%) | $52,084,000 (24.18%) | $41,943,000 (73684.21%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$134,414,000 (-19.33%) | -$112,642,000 (-216.54%) | $96,652,000 (-54.95%) | $214,521,000 (664.04%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$134,414,000 (-19.33%) | -$112,642,000 (-216.54%) | $96,652,000 (-54.95%) | $214,521,000 (664.04%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$134,414,000 (-19.33%) | -$112,642,000 (-216.54%) | $96,652,000 (-54.95%) | $214,521,000 (594.27%) |
Weighted Average Shares | $40,474,385 (13.17%) | $35,763,520 (0.59%) | $35,552,025 (1.05%) | $35,181,383 (133.29%) |
Weighted Average Shares Diluted | $40,474,385 (13.17%) | $35,763,520 (-5.30%) | $37,766,507 (-0.02%) | $37,774,790 (150.49%) |
Earning Before Interest & Taxes (EBIT) | -$120,342,000 (-10.38%) | -$109,030,000 (-173.30%) | $148,736,000 (-42.01%) | $256,464,000 (773.31%) |
Gross Profit | $35,000,000 (177.89%) | $12,595,000 (-95.29%) | $267,630,000 (-22.38%) | $344,775,000 (0%) |
Operating Income | -$159,528,000 (-5.58%) | -$151,101,000 (-219.61%) | $126,324,000 (-48.42%) | $244,901,000 (641.34%) |
ITOS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$131,151,000 (-280.50%) | $72,658,000 (116.29%) | -$446,062,000 (-35814.81%) | -$1,242,000 (-229.44%) |
Net Cash Flow from Financing | $122,241,000 (10883.02%) | $1,113,000 (-43.90%) | $1,984,000 (-45.78%) | $3,659,000 (-98.92%) |
Net Cash Flow from Operations | -$98,181,000 (5.37%) | -$103,756,000 (6.69%) | -$111,193,000 (-121.67%) | $513,140,000 (2138.21%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$109,021,000 (-224.59%) | -$33,587,000 (94.04%) | -$563,797,000 (-210.03%) | $512,381,000 (61.91%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$129,493,000 (-271.01%) | $75,723,000 (117.02%) | -$445,004,000 (0%) | $0 (0%) |
Capital Expenditure | -$1,633,000 (44.94%) | -$2,966,000 (-216.20%) | -$938,000 (20.58%) | -$1,181,000 (-231.74%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $122,718,000 (10925.88%) | $1,113,000 (20.32%) | $925,000 (-68.57%) | $2,943,000 (-98.61%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$1,930,000 (46.42%) | -$3,602,000 (57.75%) | -$8,526,000 (-168.45%) | -$3,176,000 (-289.27%) |
Share Based Compensation | $29,941,000 (10.81%) | $27,021,000 (25.32%) | $21,561,000 (56.31%) | $13,794,000 (221.39%) |
Depreciation Amortization & Accretion | $1,238,000 (37.86%) | $898,000 (11.83%) | $803,000 (33.17%) | $603,000 (12.71%) |
ITOS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% |
Profit Margin | -384.00% (57.06%) | -894.30% (-2577.29%) | 36.10% (-41.96%) | 62.20% |
EBITDA Margin | -340.30% (60.36%) | -858.50% (-1635.78%) | 55.90% (-25.07%) | 74.60% |
Return on Average Equity (ROAE) | -22.20% (-20.65%) | -18.40% (-221.85%) | 15.10% (-73.13%) | 56.20% (285.48%) |
Return on Average Assets (ROAA) | -19.30% (-19.14%) | -16.20% (-233.88%) | 12.10% (-65.33%) | 34.90% (299.43%) |
Return on Sales (ROS) | -343.80% (60.29%) | -865.70% (-1657.01%) | 55.60% (-25.27%) | 74.40% |
Return on Invested Capital (ROIC) | -24.10% (1.63%) | -24.50% (-105.26%) | 465.70% (453.88%) | -131.60% (-108.24%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -2.31 (33.46%) | -3.48 (-148.41%) | 7.18 (-5.93%) | 7.63 (165.00%) |
Price to Sales Ratio (P/S) | 8.88 (-71.44%) | 31.09 (1098.65%) | 2.59 (-45.40%) | 4.75 |
Price to Book Ratio (P/B) | 0.47 (-30.25%) | 0.68 (-34.96%) | 1.05 (-64.76%) | 2.97 (-18.98%) |
Debt to Equity Ratio (D/E) | 0.16 (1.86%) | 0.16 (16.67%) | 0.14 (-77.00%) | 0.6 (809.09%) |
Earnings Per Share (EPS) | -3.32 (-5.40%) | -3.15 (-215.81%) | 2.72 (-55.41%) | 6.1 (311.81%) |
Sales Per Share (SPS) | 0.86 (145.74%) | 0.35 (-95.32%) | 7.53 (-23.18%) | 9.8 (0%) |
Free Cash Flow Per Share (FCFPS) | -2.47 (17.36%) | -2.98 (5.39%) | -3.15 (-121.67%) | 14.55 (959.54%) |
Book Value Per Share (BVPS) | 14.58 (-9.33%) | 16.08 (-13.80%) | 18.66 (18.74%) | 15.71 (-26.68%) |
Tangible Assets Book Value Per Share (TABVPS) | 16.97 (-9.07%) | 18.67 (-12.10%) | 21.24 (-15.55%) | 25.15 (10.06%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (50.00%) | -2 (0%) | 0 (0%) | 3 (113.64%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.36 (23.88%) | -1.79 (-402.25%) | -0.36 (-112.28%) | 2.9 (112.88%) |
Asset Turnover | 0.05 (177.78%) | 0.02 (-94.63%) | 0.34 (-40.29%) | 0.56 (0%) |
Current Ratio | 12.63 (-8.26%) | 13.76 (-8.01%) | 14.96 (420.13%) | 2.88 (-87.30%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$99,814,000 (6.47%) | -$106,722,000 (4.82%) | -$112,131,000 (-121.90%) | $511,959,000 (2105.17%) |
Enterprise Value (EV) | $162,054,490 (-16.20%) | $193,373,290 (463.57%) | -$53,187,942 (-107.14%) | $745,317,458 (-11.81%) |
Earnings Before Tax (EBT) | -$120,342,000 (-10.38%) | -$109,030,000 (-173.30%) | $148,736,000 (-42.01%) | $256,464,000 (773.31%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$119,104,000 (-10.15%) | -$108,132,000 (-172.31%) | $149,539,000 (-41.83%) | $257,067,000 (784.51%) |
Invested Capital | $509,282,000 (33.26%) | $382,181,000 (-11.66%) | $432,626,000 (264.56%) | -$262,906,000 (-3713.55%) |
Working Capital | $469,179,000 (-8.12%) | $510,638,000 (-12.90%) | $586,298,000 (2.75%) | $570,589,000 (75.81%) |
Tangible Asset Value | $686,976,000 (2.90%) | $667,588,000 (-11.58%) | $754,991,000 (-14.66%) | $884,712,000 (156.77%) |
Market Capitalization | $280,580,490 (-28.40%) | $391,845,290 (-43.60%) | $694,786,058 (-57.70%) | $1,642,352,458 (38.57%) |
Average Equity | $606,763,500 (-0.91%) | $612,319,500 (-4.37%) | $640,302,500 (67.73%) | $381,741,500 (166.78%) |
Average Assets | $697,915,750 (0.52%) | $694,331,000 (-13.15%) | $799,489,750 (30.07%) | $614,666,250 (147.18%) |
Invested Capital Average | $500,356,250 (12.64%) | $444,208,750 (1290.72%) | $31,941,000 (116.39%) | -$194,823,750 (-8072.14%) |
Shares | 36,533,918 (2.09%) | 35,784,958 (0.59%) | 35,575,323 (0.85%) | 35,273,893 (0.65%) |
